Medipattern™ Corporation Adds To Reseller Network, Providing Technology To Improve Diagnosis Of Triple Negative Breast Cancer

TORONTO, ONTARIO -- (MARKET WIRE) -- February 21, 2007 -- The Medipattern Corporation (TSX VENTURE: MKI), an award-winning developer of computer-aided diagnosis (CAD) software, whose mission is to reduce the number of unnecessary biopsies performed to diagnose cancer, is pleased to announce the signing of distribution agreements with DISS, based in San Juan, Puerto Rico; and EMSOR, headquartered in Madrid, Spain. These agreements are a result of Medipattern's comprehensive strategy to establish a global distribution network for its products.

Back to news